(S (NP (PRP$ Its) (NNS shares)) (VP (VBD jumped) (NP (QP (JJR more) (IN than) (CD 50)) (NN percent)) (PP (IN on) (NP (NNP July) (CD 27))) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN company)) (VP (VBN diverted) (NP (NP (NN attention)) (PP (IN from) (NP (JJ disappointing) (JJ financial) (NNS results)))) (PP (IN by) (VP (VBG saying) (SBAR (IN that) (S (NP (NP (DT an) (JJ early) (NN look)) (PP (IN at) (NP (JJ clinical) (NNS trials) (NNS data)))) (VP (VBD showed) (NP (NP (JJ promising) (NNS results)) (PP (IN in) (VP (VBG slowing) (NP (NP (DT the) (JJ devastating) (NNS effects)) (PP (IN of) (NP (JJ multiple) (NN sclerosis))))))) (, ,) (NP (NP (DT a) (NN disease)) (PP (IN of) (NP (DT the) (JJ nervous) (NN system))))))))))))) (. .))
